Panoro Energy ASA (0N08)
London Exchange · UK · prices in NOK · close of 20 Oct 2026
Key indicators
| Last close | NOK 32.88 |
|---|---|
| 52-week range | 17.75 – 35.77 |
| Return, 1 month / 3 months | +4.8% / +25.1% |
| Return, 1 year / 3 years | +47.9% / +33.5% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 39.0% |
| Worst drawdown (1 year) | -31.4% |
| Average daily value traded | 1.00M NOK |
| Dividend yield | 5.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Panoro Energy is an independent oil and gas company that explores for and produces crude oil and natural gas, mainly through offshore fields along the coast of West Africa. Its operations include working interests in producing fields offshore Gabon and Equatorial Guinea, where it partners with other operators and sells crude oil into international markets. The company is based in Oslo, Norway, and its business centres on developing and producing hydrocarbon reserves in Africa.
Panoro Energy ASA trades under the code 0N08 on the London Exchange in UK, with its price quoted in Norwegian kroner (NOK). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Panoro Energy ASA (0N08) trades on the London Exchange in UK. It last closed at NOK 32.88 on 20 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 1,058 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 47.9% and over the last three months it rose 25.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 79 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.9% | ||
| From 52-week high | -7.0% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 25.1% | ||
| 6-month return | 6.0% | ||
| 12-month return, skipping the last month | 41.1% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.4% | ||
| Liquidity | 52 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.00M NOK | ||
| Zero-volume days | 0.0% | ||
| Income | 51 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.8% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +4.2% |
|---|---|
| 1 month | +4.8% |
| 3 months | +25.1% |
| 6 months | +6.0% |
| 1 year | +47.9% |
| 3 years | +33.5% |
| 5 years | – |
Signals
| 50-day / 200-day average | 29.92 / 27.65 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.73 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Sep 2026 | NOK 0.3740 |
| 1 Jun 2026 | NOK 0.3740 |
| 27 Feb 2026 | NOK 0.4400 |
| 28 Nov 2025 | NOK 0.7050 |
| 28 Aug 2025 | NOK 0.7050 |
| 2 Jun 2025 | NOK 0.6840 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.